Ferghana-Wellspring expects to launch their 12 Healthshares this summer.  These exchange traded funds will slice the biotechnology pie, as they will focus on specific areas of biotechnology.  There are currently ETFs covering biotechnology, but none are as specific as these funds.  Healthshares will consist of 20 stocks, whereas iShares Nasdaq Biotechnology (IBB) has more than 150 holdings.

The following is a list of the new ETFs:

  • HealthShares Autoimmune Inflation Index
  • HealthShares Cardiology Index
  • HealthShares Derma Wound Care Index
  • HealthShares Diagnostics Index
  • HealthShares Infectious Disease Index
  • HealthShares Metabolic Endocrine Index
  • HealthShares Mid Cancer Index
  • HealthShares Neuroscience Index
  • HealthShares Ophthalmology Index
  • HealthShares Respiratory Pulmonary Index
  • HealthShares Top Cancer Index
  • HealthShares Urology GI Gender Health Index
  • The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.